A B S T R A C T Thyroxine (T4) to 3,5,3'-triiodothyronine (T,) conversion was evaluated in vivo in cerebral cortex, cerebellum, and anterior pituitary of male euthyroid Sprague-Dawley rats. Tracer quantities of 125I-T4 and 131I-T3 were injected into controls and iopanoic acid-pretreated rats 3h before isolation of nuclei from these tissues. Specifically-bound nuclear 31I-T3, denoted T3(T3); 1251-T3, denoted T3(T4); and 2.51-T, were extracted and identified by chromatography. Plasma iodothyronines were similarly quantitated. In control rats, nuclear T3(T3) (percent dose per milligram DNA x 10-4) was 174+31 in cerebral cortex, 50+9 in cerebellum, and 932±+158 in pituitary (all values, mean+SEM). Nuclear T3(T4) (percent dose per milligram DNA x 10-4) was 23.3+3.3 in cortex, 3.5+0.6 in cerebellum, and 39.4±6.9 in pituitary. Two-thirds of nuclear T3(T4) derived from local T4 to T3 conversion. Nuclear T3(T4) in all tissues was reduced to less than 15% of its control value by iopanoic acid treatment and all of the residual nuclear T3(T4) could be accounted for by plasma T3(T4). Nuclear T3(T3) binding was not inhibited by iopanoic acid. These results indicate there is rapid local T4 to T3 conversion in rat brain and nuclear binding of the T3 produced. We have previously found that local T3(T4) production is the source of -50% of the T3 in rat anterior pituitary. The present observations that the ratio of locally derived nuclear T3(T4) to nuclear T3(T3) is much higher in cerebral cortex (0.1) and cerebellum (0.04) than in anterior pituitary (0.015) suggest that this locally produced T3(T4) is the predominant source of intracellular T3 in these portions of rat brain.
A B S T R A C T Thyroxine (T4) to 3,5,3'-triiodothyronine (T,) conversion was evaluated in vivo in cerebral cortex, cerebellum, and anterior pituitary of male euthyroid Sprague-Dawley rats. Tracer quantities of 125I-T4 and 131I-T3 were injected into controls and iopanoic acid-pretreated rats 3h before isolation of nuclei from these tissues. Specifically-bound nuclear 31I-T3, denoted T3(T3); 1251-T3, denoted T3(T4); and 2.51-T, were extracted and identified by chromatography. Plasma iodothyronines were similarly quantitated. In control rats, nuclear T3(T3) (percent dose per milligram DNA x 10-4) was 174+31 in cerebral cortex, 50+9 in cerebellum, and 932±+158 in pituitary (all values, mean+SEM). Nuclear T3(T4) (percent dose per milligram DNA x 10-4) was 23.3+3.3 in cortex, 3.5+0.6 in cerebellum, and 39.4±6.9 in pituitary. Two-thirds of nuclear T3(T4) derived from local T4 to T3 conversion. Nuclear T3(T4) in all tissues was reduced to less than 15% of its control value by iopanoic acid treatment and all of the residual nuclear T3(T4) could be accounted for by plasma T3(T4). Nuclear T3(T3) binding was not inhibited by iopanoic acid. These results indicate there is rapid local T4 to T3 conversion in rat brain and nuclear binding of the T3 produced. We have previously found that local T3(T4) production is the source of -50% of the T3 in rat anterior pituitary. The present observations that the ratio of locally derived nuclear T3(T4) to nuclear T3(T3) is much higher in cerebral cortex (0.1) and cerebellum (0.04) than in anterior pituitary (0.015) suggest that this locally produced T3(T4) is the predominant source of intracellular T3 in these portions of rat brain. This contrasts to the sittuation in liver, kidney, and heart where most intracellular T3 appears to be derived directly from the plasma (5) (6) (7) . Several investigators have found significant quantities of tracer T3 in brain tissue within a relatively short time after injection of labeled T4 (8, 9) . Data of Obregon et al. (10) also have suggested that the ratio of the T3 derived from injected tracer T4 to the T3 derived directly from plasma was significantly higher in brain than in liver, kidney, or heart. In the present experiments, we investigated T4 to T3 conversion in rat brain and evaluated the response to iopanoic acid, an agent which inhibits T4 to T3 conversion in rat anterior pituitary and liver (7, 11, 12) .
METHODS
Euthyroid male Sprague-Dawley rats weighing 200-300 g were obtained from Zivic-Miller, Allison Park, Penn. 10 ,Ci/ 100 g body wt 131I-T3 (-3,300 ,Ci/,ug, sp act) and about 100 ,tCi/100 g body wt 1251-T4 (2, 800 iCi/,ug, sp act) were given simultaneously by jugular injection with 200 ,ug Nal. lopanoic acid, Telepaque, was supplied by Dr. F. C. Nachod, Winthrop Laboratories, Sterling Drug Co., New York. This was dissolved in alkalinized isotonic saline and 5 mg/100 g body wt i.p. was given 24, 16, and 1.5 h before iostope addministration. Control animals received vehicle at the samne times.
Animals were killed after 3 h by exsanguination tinder light ether anesthesia anid perfused with 30 ml of cold 0.15 M NaCl retrograde throuiglh the abdominial aorta to minimize the contribuitioni of' plasma iodothyronines to cellular radioactivity.
Cell nutclei fromn anterior pituitary, cerebral cortex, and cerebellum were prepared as previouisly described (1, 11) . At least two morphologically distinict types of nuclei were seenl by phalse contrast microscopy in brain preparations.
Recovery of DNA in pituitary tissue was 80-90% and was 36 ani( 59% for cortex and cerebellum, respectively. Total DNA in the tissuies was in agreement with previous estimates (1, 2, 6) . In some experiments, 20 ,ug T3/100 g body wt was injected simuilltaneouisly with tracer to determine nonspecific nuclear T3 binding. Nonspecific T3 binding was <8% of that bound at tracer doses for pituitary and cerebellum and 20% for cortex calculated as described (1) . In all tissues, nonsp)ecific nuclear binding of 1251-T4 in rats giveni excess T3was 21-25% of that bound when tracer was given alone.
Identificationi anid quiantitation of 13'1-T3, '251-T3, and 125-IT4 bottn(l to nuclei and present in plasma was performed as previou.sly described (7, 13) . In brief, the nuclear pellets were counlted to determine total '311-T3 binding, extracted with ethanol-NIH4011, and the iodothyronines chromlatographed in tertiary aim-)yl alcohol:hexane:2 N NH4OH (5:1:6) with cold T3, T4 and I. The "T3 and T4 spots" were located by chemical staining and counted. Net '25I-T3 (above paper backgrouind and 131I-T3 crossover) was corrected for 131I-T3 losses (-30%) durinig extractioni. 3'1I-T3 counts in the "T3 sPot" in control rats ranged from 7 to 18 x 10: counts/40 min in cerebellum and pituitary aind twice that number in cortex. Net nuclear 1251-T3 was 3-12 x 103 4-12 x 103,and 40-70 x 103 counts/40 mill in cerebellum, pituitary and cortex, respectively. The counting error was <5% in all studies. Plasma 1251-T3 and '31I-T3 were isolated by affiniity chromatography followed by paper clhromcatography (7, 13) . T3 recovery determined simultaneouisly with uininjected tracer was 15-25%. The contaminatiOn of 125I-T4 with '25I-T3 varied from 0.3 to 0.5% determined in a similar maniner (7, 13) .
The contribution of plasma '25I-T3 to nuclear '25I-T3 was estimated by mutltiplication of the plasma 1251-T3 concentration by the nuclear/plasma ratio for 131I-T3 corrected for nonspecific binding. Plasma 125I-T3 is derived fromii both 1251-T3 contamninanit and 125I-T3 generated in tissues and retuirniing to plasma. Since 3-3.5 h is re(Iuired for complete e(quilibration of plasma T3 with brain niuclear T3 (1), this correction somewhat overestimiates the contrib)ultion of newly generated plasma '251-T3 to nutclear 125I-T3 and, therefore, underestimates the residual nuiclear 125 I-T3, which is that derived from local (intracellullar) T4 to T3 conversion (5-7). However, this approaclh is sufficienitly accurate for the present studies. To facilitate presentationi of these results, we will denote 31I-T3 as T3 (T3) and(l 125I-T3 as T3(T4) whether the latter was genierated from T4 de novo or present as a contaiminant in the injected tracer T4. pittuitary, cortex, and cerebellum respectively. In contrast, nuclear T3(T4) was not significantly different in pituitary and cortex but was substantially higher in both than in cerebellum. Specifically-bound nuclear 1251-T4 was found in all three tisstues. Since over 90% of the nuclear T3(T4)-that not due to inijected T3' (T4) contaminant-has been derived from1 T4 labeled in the distal ring via 5'-monodeiodination, the specific activity of the cellular T3(T4) is approximately half that of T4. Thus, in all three tissues, T3(T4) constitutes 70-80% of the 1251-labeled nuclear iodothyronines.
To determine the quantity of T:i(T4) derived from local conversion within the tissue and to evaluate the effect of iopanoic acid (IOP) on this conversion in vivo, we performed the experiments shown in Table TI . Nuclear T3(T3) and the nuclear/plasma T3(T3) ratios (not shown) were not affected by IOP pretreatment. This indicates that there is no inhibitioni of nuclear T3 binding by IOP, consistent with ouir previous results in pituitary, liver, heart, and kidney of intact rats (7) . Total nuclear T3(T4) was reduced to <15% of control by IOP pretreatment. In Table II , the quantity of nuclear T3(T4) contributed by local, i.e., intracellular, T4 to T3 conversion is calculated. About two-thirds of the nuclear T3(T4) in cortex and cerebellum in control rats is derived from local T4 5'-monodeiodination; the remainder derives from the plasma.
In IOP-treated rats, all of the residual nuclear T3(T4) could be accounted for by the T3(T4) in plasma, indicating complete inhibition of local T4 to T3 conversion in the tissues examined. An average of 87+1% (SEM) of the plasma T3(T4) in IOP-treated rats was due to injected T3(T4) contamiiinanlt as opposed to 14±1o% in controls.
DISCUSSION
The present results demonstrate that there is significanit local T4 to T3 conversion in the brain of euthyroid rats. As previously demonstrated for anterior pituitary, the T3 generated from T4 is bound to limited-capacity nuclear binding sites (5) (6) (7) . At (1, 6) . Therefore, the different quantities of nuclear T3(T3) in the various tissues can probably be attributed to these differences in nuclear binding capacities. It is apparent from Table II that total nuclear T3(T4) substantially exceeds that which can be accounted for by plasma T3(T4) alone, emphasizing the importance of local T4 to T3 conversion. Further substantiation of the important role of local conversion is indicated by the fact that nuclear T3(T4) is virtually eliminated by pretreatment of rats with IOP. These results are similar to our observations of the effect of this agent on anterior pituitary T4 to T3 conversion both in vivo and in vitro (7, 11) .
Local production of T3(T4) in rat anterior pituitary does not provide a maximum contribution to nuclear T3 until about 16 h after T4 injection (6) . The present studies do not establish when the quantities of T3(T4) in cortex and cerebellum reach a maximum. Therefore, it is not possible to make a precise gravimetric comparison of the relative contributions of T3(T3) and locally produced T3(T4) to the total nuclear T3 in brain.
However, the data in Table II suggest that the contribution of T3(T4) is substantial. The ratio of locally derived nuclear T3(T4) to nuclear T3(T3) in anterior pituitary in Table II is -0.015, whereas the ratios in cortex and cerebellum are 0.10 and 0.04, respectively. This suggests that the contribution of local T4 to T3 conversion to nuclear T3 (and total cellular T3) would be even greater in cortex and cerebellum than the 50% that it contributes in anterior pituitary. Therefore, plasma T4, through its local conversion to T3 in the brain, may be the predominant source of intracellular T3 in the cerebral cortex and cerebellum of the rat. Studies are currently underway to substantiate these estimates. If these speculations are confirmed, it would suggest that, analogous to the situation in anterior pituitary and unlike that in liver, kidney, or heart, establishment of normal intracellular T3 concentrations in cortex and cerebellumiof hypothyroid rats would require normalization of serum T4 as well as serum T3. If this proves to be the case in man as well, this concept would have special importance in the proper treatment of congenital hypothyroidism.
